PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCN15
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $65,547
Award facts
- Contract value 100% obligated
- $65,546.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $65,546.64 with an ultimate completion date of January 20, 2026, was awarded on January 19, 2026, to AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) by the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award through open competition. The place of performance is Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. The parent company, Cencora, Inc., also maintains a separate $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical through December 31, 2031, and holds additional contracts with the Department of Veterans Affairs and Department of Justice. The company's federal contract portfolio demonstrates extensive capability in delivering both brand-name and generic medications, specialty pharmaceuticals for oncology, diabetes, neurological, and pain management applications, as well as critical medical supplies such as syringes, vials, and test kits.
Quick answers
Who was awarded contract SPE2D826FCN15?
SPE2D826FCN15 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826FCN15 worth?
The government has obligated $65,547 on SPE2D826FCN15.
Is contract SPE2D826FCN15 an order under another contract?
Yes. SPE2D826FCN15 is a delivery order under SPE2DX22D0019, an indefinite delivery contract.
Was contract SPE2D826FCN15 competed?
The extent of competition for SPE2D826FCN15 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award